GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Cash From Other Investing Activities

A Plus Biotechnology Co (ROCO:6918) Cash From Other Investing Activities : NT$0.2 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is A Plus Biotechnology Co Cash From Other Investing Activities?

Cash from other investing activities means the cash received by a company that comes from other investing activities.

A Plus Biotechnology Co's cash from other investing activities for the six months ended in Jun. 2024 was NT$0.2 Mil. It means A Plus Biotechnology Co received NT$0.2 Mil from other investing activities. A Plus Biotechnology Co's cash from other investing activities for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.2 Mil.

A Plus Biotechnology Co Cash From Other Investing Activities Historical Data

The historical data trend for A Plus Biotechnology Co's Cash From Other Investing Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

A Plus Biotechnology Co Cash From Other Investing Activities Chart

A Plus Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash From Other Investing Activities
-0.34 -140.04 -9.32 6.27 4.96

A Plus Biotechnology Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash From Other Investing Activities Get a 7-Day Free Trial Premium Member Only 4.36 1.91 4.93 0.03 0.16

A Plus Biotechnology Co Cash From Other Investing Activities Calculation

Cash from other investing activities means the cash received by a company that comes from other investing activities.

Cash From Other Investing Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A Plus Biotechnology Co Cash From Other Investing Activities Related Terms

Thank you for viewing the detailed overview of A Plus Biotechnology Co's Cash From Other Investing Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

A Plus Biotechnology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » A Plus Biotechnology Co Ltd (ROCO:6918) » Definitions » Cash From Other Investing Activities
Comparable Companies
ROCO:4188 ROCO:6649 ROCO:4735 ROCO:6572 ROCO:6955 ROCO:4161 ROCO:7555 ROCO:6767 ROCO:6797 TPE:6598 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 21, Qiaohe Road, 3rd Floor, Zhonghe District, New Taipei City, TWN
Website
https://www.aplusbio.com
A Plus Biotechnology Co Ltd provides orthopedic implants. It engages in the research and development of orthopedic medical products. Aplus locking plate systems feature superior anatomical bone curves and 5-axis CNC manufacturing technology.

A Plus Biotechnology Co Headlines

No Headlines